Introduction
Expression of Ia molecules by accessory cells, such as peripheral blood adherent monocytes (Mq),' is necessary for their ability to initiate and regulate immune reactivity (1) (2) (3) (4) . In mice, two Ia molecules, I-E and I-A, encoded for by genes within the I region have been described. In humans, three groups of molecules whose general structure resembles murine Ia molecules have been delineated, HLA-DC (DS), HLA-DR, and HLA-SB (5) (6) (7) (8) (9) (10) (11) (12) (13) . Published studies indicate that two of these, HLA-SB and HLA-DR, have a tissue distribution similar to that described for murine Ia molecules. Both HLA-SB and HLA-DR are displayed by B cells and MO (4, (11) (12) (13) . In contrast to these studies, little is known about the tissue distribution of HLA-DC. We have previously provided indirect evidence indicating that although HLA-DC is present on the surface of MO, only -50% of peripheral blood MO are HLA-DC+ (14) . This suggests that there is heterogeneity among peripheral MO in regards to Ia expression. Furthermore, other studies from our laboratory have demonstrated that the human monocytoid cell line U-937 can be induced to express HLA-DR. This expression represents a pretranslational event induced by human recombinant gamma interferon (IFN-'y, 15). In those experiments, expression of HLA-DC was never seen with the expression of HLA-DR. This suggests that not only may there be discoordinate expression of HLA-DR and HLA-DC in normal MO but that the regulatory signals governing expression of these Ia antigens may be different. Studies in the murine system have demonstrated that both I-A and I-E can be induced by a soluble factor released by activated T cells (16) (17) (18) (19) (20) (21) . One of these factors has been demonstrated to be IFN-'y (22) (23) . In the human, however, only modulation of HLA-DR expression by supernatants of activated T cells and IFN--y has been studied (24) (25) (26) (27) .
In the present study, we investigated the heterogeneity of M4) Ia expression directly by using a monoclonal antibody specific for HLA-DR, two monoclonal antibodies specific for HLA-DC molecules, and a rabbit heterosera specific for HLA-DC molecules. We demonstrate that there is discoordinate expression of HLA-DR and HLA-DC among normal human peripheral monocytes. However, despite discoordinate expression, both Ia molecules appear to be under the regulatory control of the lymphokine IFN-y. We also demonstrate that IFN-y can modulate the expression of another M)0 marker, MAC 120.
Methods
Antibodies. CA 206 is an IgG2b mouse monoclonal antibody that is specific for nonpolymorphic determinants of HLA-DR molecules (14) . RbO3 is a rabbit serum that is directed against Ia molecules whose amino acid sequence is distinct from HLA-DR and homologous to murine I-A (5, 6, 14) . These molecules have been termed HLA-DS or DC (6, 7) and for convenience will be called HLA-DC in this paper. Leu 10 is an IgGI mouse monoclonal antibody, which was a gift from the Becton-Dickinson Monoclonal Center, Inc., Mountain View, CA. Leu 10 was derived from the fusion of mouse NS-I cells with spleen cells of BALB/c mice immunized with tonsillar B cells (Chen, Y. X., F. Brodsky, R. L. Evans, and N. L. Warner, manuscript in preparation). It reacts with B cells of all DR specificities except for homozygous DR 3 and DR 7 cells and the molecule it depicts is distinct from HLA-DR. On the basis of competitive binding and sequential immunoprecipitation, Leu 10 appears to react with HLA-DC molecules (28). Studies from our laboratory indicate that Leu 10 immunoprecipitates an Ia molecule distinct from HLA-DR and electrophoretically identical to that precipitated by a known anti HLA-DC sera, RbO3 (Gonwa, T., and J. Stobo; unpublished observations). Genox 3.53 is a mouse monoclonal antibody known to be directed against an HLA-DC molecule associated with HLA-DR 1, 2, and 6 (8) . This molecule has an amino acid sequence distinct from HLA-DR, identical to that precipitated by RbO3, and homologous to murine I-A (7) . It Fluorescent analysis was performed by using an indirect immunofluorescent technique. Cells to be analyzed were incubated with the first antibody under saturating conditions for 30 min at 4°C, washed, and incubated with saturating amounts of either an F(ab')2 fluoresceinated goat anti-mouse antibody or an F(ab')2 fluoresceinated goat antirabbit Ig antibody. Controls consisted of cells incubated with either an isotype matched myeloma protein or normal rabbit serum in the first step followed by the fluoresceinated second antibody (Cappel Laboratories, West Chester, PA) for 30 min at 4°C. Cells were then washed twice over 5% bovine serum albumin, resuspended in phosphatebuffered saline, and analyzed by flow cytometry using log amplification on an FACS IV (Becton-Dickinson & Co.). This technique has been previously described (14) .
Isolation and culture of peripheral blood monocytes. Peripheral blood mononuclear cells (PBMC) were obtained from normal donors and adhered on plastic petri dishes as previously described (29). Nonadherent cells were removed by vigorous washing. Adherent cells were removed with lidocaine as described (29) (14, 31, 33, 34) . Previous studies from this laboratory provided indirect evidence suggesting that only -50% of peripheral blood MO also display easily detectable HLA-DC molecules (14) . To directly analyze the display of HLA-DC by MO, saturating amounts of Leu 10 were used to stain peripheral blood MO from normal donors. A typical experiment is depicted in Fig. 1 However, the data presented in Fig. 2 
